Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Mauri is active.

Publication


Featured researches published by P. Mauri.


Pathology Research and Practice | 1992

Cell kinetics of melanocytes in common and dysplastic nevi and in primary and metastatic cutaneous melanoma.

C. Urso; Roberto Bondi; M. Balzi; Scubla E; P. Mauri; A. Becciolini; S. Tarocchi; C. Vallecchi

The 3H-thymidine labelling (LI) and mitotic (MI) indexes were calculated in 29 cutaneous melanocytic lesions: 6 common nevi (CN), 11 dysplastic nevi, subclassified as nevi with architectural atypia (NAA = 4) and nevi with cyto-architectural atypia (NCAA = 7), 2 melanomas in situ (MIS), 4 invasive superficial spreading melanomas (IM) and 6 metastatic melanomas (MM). The LI mean values resulted to be: CN = 0.23%, NAA = 0.98%, NCAA = 1.79%, MIS = 5.75%, IM = 5.16%, MM = 3.80%. In CN, NAA, NCAA and MIS, these values were calculated at epidermal level; in IM and MM at dermal level. At dermal level, the LI mean values of CN, NAA and NCAA were: 0.20%, 0.20%, 0.23% respectively. The MI mean value was close to 0 in CN, NAA, NCAA, MIS; 0.18% in IM, 0.16% in MM. Confirming a low proliferative activity in CN and a high activity in melanomas (MIS, IM, MM), the results showed that dysplastic nevi (NAA, NCAA) had a proliferative activity intermediate between common nevi and melanomas. The lesions with melanocytic atypia (NCAA) resulted to have a higher proliferative activity than those without this histological feature (NAA).


in Vivo | 1993

Proliferative activity in normal colon mucosa and tumor tissue: clinical implications.

M. Balzi; A. Becciolini; P. Mauri; Larosa; Paolo Bechi


International Journal of Biological Markers | 1993

Multivariate analysis of prognostic value of 3H-thymidine labeling index (TLI) in laryngeal carcinoma.

M. Balzi; P. Mauri; P. Boanini; Valentino Giachè; M. B. Ninu; N. Zarone; Annibale Biggeri; Omero Fini-Storchi; Roberto Bondi; A. Becciolini


Convegno | 1994

Evaluation of proliferative activity in bladder cancer: prognostic and therapeutic aspects.

G. B. Muraro; M. Balzi; F. Melone; A. Dami; U. Farina; E. Zanieri; P. Mauri; A. Becciolini


International Journal of Biological Markers | 1993

Human solid tumors: variability of proliferative activity within the tumor.

M. Balzi; P. Mauri; P. Boanini; A. Maugeri; Valentino Giachè; A. Becciolini


Convegno | 1992

Relation between TLI, clinic histopathologic parameters and prognosis in bladder carcinoma.

M. Balzi; A. Becciolini; E. Zanieri; P. Mauri; P. Boanini; F. Melone; Simonetta Bianchi; A. Maugeri; G. B. Muraro; C. Biagini


Convegno | 1992

Prognostic significance of TLI in bladder carcinomas.

M. Balzi; A. Becciolini; E. Zanieri; P. Mauri; A. Maugeri; Simonetta Bianchi; F. Melone; G. B. Muraro; Annibale Biggeri


International Journal of Biological Markers | 1991

The proliferative activity of bladder carcinomas.

M. Balzi; E. Zanieri; A. Becciolini; P. Mauri; F. Melone; A. Giannini


Convegno | 1991

Proliferative characterization of bladder transitional cell carcinoma.

M. Balzi; A. Becciolini; E. Zanieri; F. Melone; Simonetta Bianchi; P. Mauri; Valentino Giachè; G. B. Muraro


Convegno | 1991

Correlation between the proliferative activity and clinical-histopathologic parameters in breast carcinoma.

M. Balzi; P. Mauri; P. Boanini; Simonetta Bianchi; Luigi Cataliotti; Gaetano Cardona; P. Pacini; Gianni Messeri; A. Becciolini

Collaboration


Dive into the P. Mauri's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Balzi

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Urso

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge